{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:40:40Z","timestamp":1787928040949,"version":"build-2784847793"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Don Heineking Research Fund"},{"name":"Hadley-Carver Chair in Glaucoma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Nanophthalmos has a significant genetic background and disease-causing mutations have been recently been reported in the myelin regulatory factor (<jats:italic>MYRF<\/jats:italic>) gene. We report clinical features in a patient with nanophthalmos and a Thr518Met <jats:italic>MYRF<\/jats:italic> mutation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A three-year-old male was discovered to have nanophthalmos after first presenting to the emergency department for a frontal headache, eye pain, emesis, and lethargy. Imaging studies (CT and MRI) were negative except for increased posterior fossa cerebrospinal fluid. Subsequent examinations revealed nanophthalmos (short axial eye lengths 18.1\u2009mm OD and 18.3\u2009mm OS), microcornea, and a large crystalline lens. Peripheral chorioretinal pigment abnormalities were also observed. He experienced episodes of marked ocular hypertension (53\u2009mmHg OD and 60\u2009mmHg) likely due to intermittent angle closure precipitated by nanophthalmos. The ocular hypertension was responsive to topical medicines. Genetic analysis of known nanophthalmos genes <jats:italic>MFRP<\/jats:italic> and <jats:italic>TMEM98<\/jats:italic> were negative, while a novel mutation, Thr518Met was detected in <jats:italic>MYRF<\/jats:italic>. The Thr518Met mutation was absent from 362 matched normal controls and was extremely rare in a large population database, allele frequency of 0.000024. The Thr518Met mutation altered a highly conserved amino acid in the MYRF protein and three of four algorithms suggested that this mutation is likely pathogenic. Finally, molecular modeling showed that the Thr518Met mutation is damaging to MYRF structure. Together these data suggest that the Thr518Met mutation causes nanophthalmos.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Nanophthalmos may present at an early age with features of angle closure glaucoma and a Thr518Met mutation in <jats:italic>MYRF<\/jats:italic> was detected in a patient with nanophthalmos. Prevalence data, homology data, mutation analysis data, and protein modeling data suggest that this variant is pathogenic and may expand the phenotypic range of syndromic nanophthalmos caused by <jats:italic>MYRF<\/jats:italic> mutations to include central nervous system abnormalities (increased posterior fossa cerebrospinal fluid).<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12886-020-01659-8","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T09:03:58Z","timestamp":1601543038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nanophthalmos patient with a THR518MET mutation in MYRF, a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Joshua","family":"Hagedorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Avdic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Schnieders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young H.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene V.","family":"Drack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin A.","family":"Boese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0377-0479","authenticated-orcid":false,"given":"John H.","family":"Fingert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"issue":"3","key":"1659_CR1","first-page":"2735465","volume":"2018","author":"PC Carricondo","year":"2018","unstructured":"Carricondo PC, Andrade T, Prasov L, Ayres BM, Moroi SE. Nanophthalmos: a review of the clinical Spectrum and genetics. J Ophthalmol. 2018;2018(3):2735465\u20139.","journal-title":"J Ophthalmol"},{"issue":"5","key":"1659_CR2","doi-asserted-by":"publisher","first-page":"e1008130","DOI":"10.1371\/journal.pgen.1008130","volume":"15","author":"SJ Garnai","year":"2019","unstructured":"Garnai SJ, Brinkmeier ML, Emery B, Aleman TS, Pyle LC, Veleva-Rotse B, et al. Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice. PLoS Genet. 2019;15(5):e1008130.","journal-title":"PLoS Genet"},{"issue":"10","key":"1659_CR3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00439-019-02039-z","volume":"138","author":"X Xiao","year":"2019","unstructured":"Xiao X, Sun W, Ouyang J, Li S, Jia X, Tan Z, et al. Novel truncation mutations in MYRF cause autosomal dominant high hyperopia mapped to 11p12-q13.3. Hum Genet. 2019;138(10):1077\u201390.","journal-title":"Hum Genet"},{"key":"1659_CR4","first-page":"527","volume":"25","author":"OM Siggs","year":"2019","unstructured":"Siggs OM, Souzeau E, Breen J, Qassim A, Zhou T, Dubowsky A, et al. Autosomal dominant nanophthalmos and high hyperopia associated with a C-terminal frameshift variant in MYRF. Mol Vis. 2019;25:527\u201334.","journal-title":"Mol Vis"},{"issue":"8","key":"1659_CR5","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1167\/iovs.18-26275","volume":"60","author":"C Guo","year":"2019","unstructured":"Guo C, Zhao Z, Chen D, He S, Sun N, Li Z, et al. Detection of clinically relevant genetic variants in Chinese patients with Nanophthalmos by trio-based whole-genome sequencing study. Invest Ophthalmol Vis Sci. 2019;60(8):2904\u201313.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1659_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cell.2009.04.031","volume":"138","author":"B Emery","year":"2009","unstructured":"Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, Mulinyawe SB, et al. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell. 2009;138(1):172\u201385.","journal-title":"Cell."},{"issue":"4","key":"1659_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/ajmg.a.38620","volume":"176","author":"H Pinz","year":"2018","unstructured":"Pinz H, Pyle LC, Li D, Izumi K, Skraban C, Tarpinian J, et al. De novo variants in myelin regulatory factor (MYRF) as candidates of a new syndrome of cardiac and urogenital anomalies. Am J Med Genet A. 2018;176(4):969\u201372.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"1659_CR8","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1002\/ajmg.a.40360","volume":"176","author":"D Chitayat","year":"2018","unstructured":"Chitayat D, Shannon P, Uster T, Nezarati MM, Schnur RE, Bhoj EJ. An additional individual with a De novo variant in myelin regulatory factor (MYRF) with cardiac and urogenital anomalies: further proof of causality: comments on the article by Pinz et al. (). Am J Med Genet A. 2018;176(9):2041\u20133.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"1659_CR9","doi-asserted-by":"publisher","first-page":"e1007822","DOI":"10.1371\/journal.pgen.1007822","volume":"14","author":"H Qi","year":"2018","unstructured":"Qi H, Yu L, Zhou X, Wynn J, Zhao H, Guo Y, et al. De novo variants in congenital diaphragmatic hernia identify MYRF as a new syndrome and reveal genetic overlaps with other developmental disorders. PLoS Genet. 2018;14(12):e1007822.","journal-title":"PLoS Genet"},{"issue":"1","key":"1659_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ana.25125","volume":"83","author":"H Kurahashi","year":"2018","unstructured":"Kurahashi H, Azuma Y, Masuda A, Okuno T, Nakahara E, Imamura T, et al. MYRF is associated with encephalopathy with reversible myelin vacuolization. Ann Neurol. 2018;83(1):98\u2013106.","journal-title":"Ann Neurol"},{"issue":"2","key":"1659_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jsb.2018.04.007","volume":"203","author":"B Chen","year":"2018","unstructured":"Chen B, Zhu Y, Ye S, Zhang R. Structure of the DNA-binding domain of human myelin-gene regulatory factor reveals its potential protein-DNA recognition mode. J Struct Biol. 2018;203(2):170\u20138.","journal-title":"J Struct Biol"},{"issue":"3","key":"1659_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bpj.2019.06.030","volume":"117","author":"MR Tollefson","year":"2019","unstructured":"Tollefson MR, Litman JM, Qi G, O\u2019Connell CE, Wipfler MJ, Marini RJ, et al. Structural insights into hearing loss genetics from polarizable protein repacking. Biophys J. 2019;117(3):602\u201312.","journal-title":"Biophys J"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01659-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T01:20:56Z","timestamp":1633051256000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01659-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1659"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01659-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"7 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the University of Iowa\u2019s Internal Review Board and adhered to the tenets of the Declaration of Helsinki. Written informed consent to participate was provided by the participant\u2019s parent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participant\u2019s parent provided written consent for a research report to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}